Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Micronisation System
 Theranostic Nanomedicines
 Bispecific T-cell Engagers
May 2019   e-Newsletter Media Pack    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
Turkish Cargo
News
Vertex and Kymera Therapeutics Establish Strategic Collaboration...
Intec Pharma Announces Research Collaboration Agreement With Merck
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer...
 
Press Releases
Helsinn and Mundipharma China Pharmaceutical together announce...
Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced...
Lonza Chooses Synpromics’ Novel Inducible Promoter Platform to Manufacture...
 
Events
28 - 30 May 2019
8th Annual Biologics Manufacturing Korea 2019
11 - 12 Jun 2019
2nd Annual Pharmaceutical Compliance Congress Canada 2019
18 - 20 Jun 2019
Pharmaceutical Packaging and Labelling Summit 2019
Articles
  Industry 4.0: A Closed Micronisation System
Samuele Bissola, Technical Sales Manager, FPS
Recently, FPS and a major European manufacturer of API (Active Pharmaceutical Ingredient) had to face a challenging project concerning the micronisation process of a specific product. In our R&D and Test Centre some trials have been performed in order to obtain...
  Ligand Decorated Theranostic Nanomedicines
Md. Habban Akhter, Assistant Professor, Faculty of Pharmacy, DIT University
The use of nanomedicines in cancer therapy has been extensively focused in preclinical study and clinical application in past few decades. In spite of the fact, majority of nanomedicine based on the biocompatible lipidic nanocarrier with employing simple fabrication...
Food and Pharma Systems
Techno Trends
  Wistar Scientists Develop Innovative Synthetic DNA-based Cancer...
  UW–Madison School of Pharmacy Designs New Compounds to Fight...
Rousselot
Projects
  BioVectra Inc. Announces US$144.6 million Expansion
  MaSTherCell SA Announces New Manufacturing Facility in Belgium
Vetter Pharma
Qatar Cargo
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Archives
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555